Skip to content

Clinical trials

Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 2 Country / region: Canada Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20023
20043
20053
20063
20071
20091
20121
20141
20151
20181
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb6
Astex Pharmaceuticals, Inc.3
Novartis Pharmaceuticals3
Teva Branded Pharmaceutical Products R&D, Inc.2
National Cancer Institute (NCI)1
Pfizer1
Shire1
Takeda1
University Health Network, Toronto1
Versailles Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive20
Leukemia6
Blast Crisis4
Hematologic Diseases2
Leukemia, Myeloid2
Precursor Cell Lymphoblastic Leukemia-Lymphoma2
Bone Marrow Diseases1
Bronchiolitis Obliterans Syndrome1
Leukemia, Myeloid, Accelerated Phase1
Leukemia, Myeloid, Chronic-Phase1

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.